Encore Medical
Eagan, US · Founded 2017 · Minnesota corporation
Find your way into Encore Medical
Sign up to find every way you can get introduced to Encore Medical
- Your email: who you already know at Encore Medical, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Encore Medical team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Encore Medical develops cardiovascular medical devices, with clinical work focused on patent foramen ovale (PFO) and related conditions such as migraine. It operates in the cardiovascular medical device sector.
Founders & leadership
PB
Peter BuonomoSenior Vice President | Member, Board of Directors
CJ
Christopher J. TurnbullNamed on SEC filing
SS
Scott S. RobinsonTreasurer & Vice President of Finance | Member, Board of Directors
JA
Joseph A. MarinoPresident & CEO | Chairman of the Board of Directors
MC
Michael CorcoranNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$1.3M disclosed across 2 rounds · 2020–2022
▶$1.1MraisedMay 2022 · 9 investors · Other Health CareRule 506(b)
▶$1.1MraisedMay 2022 · 9 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Christopher J. TurnbullDirector
- Michael CorcoranExecutive Officer, Director
- Scott S. RobinsonExecutive Officer
- Joseph A. MarinoExecutive Officer, Director
- Todd JohnsonDirector, Promoter
- Offering amount
- $2.5M
- Amount sold
- $1.1M
- Sales commissions
- $275K
- Proceeds to insiders
- $250K
- Placement agents
- Cedar Point Capital, LLC
- First sale
- Apr 2022
- Incorporated
- Corporation, Minnesota, 2017
- Federal exemptions
- 06b
▶$250KraisedDec 2020 · 4 investors · Other Health CareRule 506(b)
▶$250KraisedDec 2020 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Christopher J. TurnbullDirector
- Scott S. RobinsonExecutive Officer
- Joseph A. MarinoExecutive Officer, Director
- Michael CorcoranExecutive Officer, Director
- Offering amount
- $6M
- Amount sold
- $250K
- Sales commissions
- $550K
- Proceeds to insiders
- $250K
- Placement agents
- Cedar Point Capital, LLC
- First sale
- Dec 2020
- Incorporated
- Corporation, Minnesota, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 1
Companies working in the same space as Encore Medical.
Frequently asked questions
- What does Encore Medical do?
- Encore Medical develops cardiovascular medical devices, with clinical work focused on patent foramen ovale (PFO) and related conditions such as migraine. It operates in the cardiovascular medical device sector.
- How much funding has Encore Medical raised?
- Encore Medical has disclosed $1.3M raised across 2 rounds.
- Where is Encore Medical headquartered?
- Encore Medical is headquartered in Eagan, US.
